title: Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?
abstract: The association between podoplanin and ezrin in the process of odontogenic tumors invasion has been suggested, but was not studied yet. Our purpose was to investigate the relationship between podoplanin and ezrin expressions in the odontogenic epithelium of ameloblastomas. Forty-seven ameloblastomas were analyzed by immunohistochemistry using anti-podoplanin and anti-ezrin antibodies. The expressions of both proteins were evaluated using a score method and the comparison and association between these proteins were verified, respectively, by Wilcoxon Signed-Rank test and by Spearman's rank correlation coefficient, using a statistical significance level of 0.05. The majority of tumors (87.2%) exhibited strong membranous expression of podoplanin in the peripheral cells. Cytoplasmic expression of ezrin in the peripheral cells of ameloblastomas was stronger than its membranous expression. No statistically significant correlation was observed between podoplanin and ezrin. However, there was statistically significant difference between membranous podoplanin and membranous ezrin expressions, between cytoplasmic podoplanin and membranous ezrin expressions, and between cytoplasmic podoplanin and cytoplasmic ezrin expressions. There was no statistical difference between membranous podoplanin and cytoplasmic ezrin expressions. These results suggest a synergistic role of both proteins in the process of invasion of ameloblastomas.
authors.affiliation: University of São Paulo. yarabruna@hotmail.com.
authors.forename: Y F
authors.initials: YF
authors.lastname: Costa
authors.forename: K C
authors.initials: KC
authors.lastname: Tjioe
authors.forename: S
authors.initials: S
authors.lastname: Nonogaki
authors.forename: F A
authors.initials: FA
authors.lastname: Soares
authors.forename: J R Pereira
authors.initials: JR
authors.lastname: Lauris
authors.forename: D Tostes
authors.initials: DT
authors.lastname: Oliveira
mesh_terms: D000293:Adolescent; D000328:Adult; D000564:Ameloblastoma / Q000503:physiopathology*; D002648:Child; D003598:Cytoskeletal Proteins / Q000235:genetics / Q000378:metabolism*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D007573:Jaw Neoplasms / Q000503:physiopathology*; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000503:physiopathology; D000099149:Ezrin; D000098853:Podoplanin
chemical_list: D003598:Cytoskeletal Proteins; D008562:Membrane Glycoproteins; D000099149:Ezrin; C117468:PDPN protein, human; D000098853:Podoplanin
references.citation: Arch Oral Biol. 2013 Apr;58(4):408-15
references.pmid: 22763018
references.citation: Nat Rev Mol Cell Biol. 2004 Aug;5(8):635-46
references.pmid: 15366707
references.citation: Oral Dis. 2012 Oct;18(7):673-9
references.pmid: 22443371
references.citation: Oncol Lett. 2014 Mar;7(3):627-630
references.pmid: 24527067
references.citation: Int J Cancer. 2011 Sep 15;129(6):1404-9
references.pmid: 21105028
references.citation: PLoS One. 2013;8(1):e54881
references.pmid: 23357878
references.citation: Anticancer Res. 2013 Sep;33(9):3969-76
references.pmid: 24023336
references.citation: Pathol Res Pract. 2012 Mar 15;208(3):140-6
references.pmid: 22326634
references.citation: Oral Implantol (Rome). 2012 Apr;5(2-3):33-41
references.pmid: 23285404
references.citation: Int J Biochem Cell Biol. 2011 Jun;43(6):886-96
references.pmid: 21376833
references.citation: Head Neck Pathol. 2012 Jun;6(2):232-43
references.pmid: 22228071
references.citation: J Oral Pathol Med. 2010 Jan;39(1):115-20
references.pmid: 20359309
references.citation: Nat Rev Mol Cell Biol. 2002 Aug;3(8):586-99
references.pmid: 12154370
references.citation: Anticancer Res. 2012 May;32(5):2125-7
references.pmid: 22593499
references.citation: J Oral Sci. 2012;54(2):165-75
references.pmid: 22790409
references.citation: Head Neck. 2006 Nov;28(11):1018-27
references.pmid: 16783828
references.citation: Mod Pathol. 1997 Feb;10(2):98-104
references.pmid: 9127314
references.citation: J Oral Pathol Med. 2010 Jan;39(1):110-4
references.pmid: 19925582
references.citation: Nat Rev Mol Cell Biol. 2010 Apr;11(4):276-87
references.pmid: 20308985
references.citation: J Oral Pathol Med. 2015 Jan;44(1):51-8
references.pmid: 25059841
references.citation: Cancer. 2006 Aug 1;107(3):563-9
references.pmid: 16804930
references.citation: In Vivo. 2011 Mar-Apr;25(2):259-64
references.pmid: 21471544
references.citation: J Cell Sci. 2006 Nov 1;119(Pt 21):4541-53
references.pmid: 17046996
references.citation: J Clin Pathol. 2007 Feb;60(2):185-9
references.pmid: 16698950
references.citation: Front Immunol. 2012 Sep 12;3:283
references.pmid: 22988448
references.citation: Blood. 2010 Nov 18;116(20):4376-84
references.pmid: 20716773
references.citation: J Oral Sci. 2011 Mar;53(1):67-75
references.pmid: 21467817
references.citation: Cancer Cell. 2006 Apr;9(4):261-72
references.pmid: 16616332
references.citation: Int J Cancer. 2005 Mar 1;113(6):899-910
references.pmid: 15515019
references.citation: Virchows Arch. 2010 May;456(5):473-82
references.pmid: 20393745
references.citation: Histopathology. 2001 Aug;39(2):179-86
references.pmid: 11493335
references.citation: Br J Cancer. 2007 Jan 15;96(1):1-5
references.pmid: 17179989
references.citation: Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):913-8
references.pmid: 19215825
references.citation: J Oral Pathol Med. 2010 Jan;39(1):103-9
references.pmid: 19691459
references.citation: Cell Adh Migr. 2011 Mar-Apr;5(2):199-206
references.pmid: 21343695